The effect of estrogen receptor status on survival in patients with endometrial cancer.
This study demonstrates a significantly increased survival time for women with estrogen receptor-positive adenocarcinoma of the endometrium when compared with that of those with estrogen receptor-negative tumors (p less than 0.05). This prognostic factor provides information which is additional to, and independent of, that provided by the histologic grade and myometrial penetration of the tumor.
D000230:Adenocarcinoma / Q000032:analysis / Q000401:mortality* / Q000473:pathology; D000368:Aged; D005260:Female; D006801:Humans; D008875:Middle Aged; D011379:Prognosis; D011960:Receptors, Estrogen / Q000032:analysis*; D014594:Uterine Neoplasms / Q000032:analysis / Q000401:mortality* / Q000473:pathology
D011960:Receptors, Estrogen